Myocardial Perfusion Imaging
- Myocardial perfusion imaging (MPI) compares heart muscle blood flow under stress versus at rest — it's a relative map of "who's getting fed."
- A spot that looks normal at rest but goes dim under stress is reversible ischemia (live but starved muscle). A spot that's dim on both is a fixed defect (usually scar).
- We stress the heart either by exercise or with a drug, inject a radiotracer at peak stress, and image where it lands.
- The classic trap is attenuation artifact — breast tissue or a big diaphragm dimming the picture and faking a defect.
- It answers a clinical question CT can't: not "is the pipe narrowed?" but "does that narrowing actually starve the muscle?"
A coronary angiogram or coronary CTA shows you the plumbing — how narrow the pipes are. But a 60% narrowing might be totally fine at rest and only cause trouble when you sprint for the bus. Myocardial perfusion imaging (MPI) skips the plumbing diagram entirely and asks the question that actually matters: when this heart is working hard, is every part of the muscle still getting fed?
The core idea: stress versus rest
Think of the heart muscle as a lawn and the coronary arteries as the sprinkler system. At rest, even a half-clogged sprinkler line keeps its patch of grass green — there's plenty of slack. But crank the water pressure way up (stress) and suddenly the healthy lines deliver a downpour while the clogged one can only manage a trickle. That patch goes brown by comparison.
MPI works exactly this way. We inject a radiotracer that flows into heart muscle in proportion to blood flow, take pictures, and look for the brown patch. The whole study is relative — we're not measuring absolute flow, we're comparing one wall to its neighbors and stress to rest.
MPI doesn't tell you a vessel is narrowed. It tells you a narrowing is flow-limiting — that the muscle downstream actually goes hungry when pushed.
How we make the heart sweat
You can't just ask the patient to think stressful thoughts. There are two ways:
- Exercise on a treadmill — the gold standard if they can do it, because you also get heart-rate and symptom information for free.
- Pharmacologic stress for people who can't walk far. Vasodilator drugs widen the healthy coronaries so the diseased one looks comparatively stingy (the lawn analogy again — turning up the pressure). There's also a drug that genuinely speeds the heart up to mimic exercise.
At peak stress we inject the tracer, because the tracer freezes a snapshot of blood flow at the moment of injection. Then we image. On a separate rest day or rest acquisition, we do it again with no stress.
Vasodilator stress is the one with the safety checklist. Active wheezing, severe reactive airway disease, and recent caffeine (which blocks the drug) are the usual reasons to switch agents or postpone. This is a "know before you inject" study, not a "wing it" study.
Reading the maps
You end up with two sets of images — stress and rest — usually sliced the heart three ways (short axis, vertical long axis, horizontal long axis) so every wall gets seen. Then it's pattern recognition:
| Stress | Rest | Meaning |
|---|---|---|
| Defect (dim) | Normal | Reversible — live, ischemic muscle. The actionable finding. |
| Defect (dim) | Defect (dim) | Fixed — usually old infarct/scar. |
| Normal | Normal | No flow-limiting disease in that territory. |
A reversible defect is the one cardiology cares about, because it flags muscle that's alive but in danger — the kind of thing a stent or bypass can rescue. A fixed defect is generally scar that's already cashed in its chips.
Most studies are also gated — synced to the ECG — so on top of perfusion you get the heart squeezing in a little movie, giving you wall motion and ejection fraction in the same sitting. Two answers for one injection.
The trap that fools everyone
The single most important pitfall is attenuation artifact. The tracer's signal has to climb out through the chest to reach the camera, and anything dense in the way — breast tissue, a high diaphragm, a big belly — soaks up signal and creates a dim patch that mimics a real defect.
A classic fake-out: breast tissue dimming the anterior wall, or a raised diaphragm dimming the inferior wall. The tells that it's artifact, not disease — the dim area doesn't change between stress and rest (a real ischemic defect should), and wall motion is preserved on the gated images. Dead or starved muscle doesn't squeeze normally; an artifact does.
This is why gating and attenuation-correction techniques (and sometimes re-imaging in a different position) earn their keep. If the wall moves normally and the "defect" sits exactly where you'd expect tissue to be in the way, suspect physics before you suspect the patient.
Where it fits
MPI lives at the crossroads of nuclear medicine and cardiology. If the radiotracer side feels mysterious, it's worth a quick detour through how nuclear medicine works — the "inject something that emits, then photograph where it goes" logic is the same here as for a bone scan.
The takeaway: anatomy tells you the pipe is narrow; MPI tells you whether that narrowing is actually starving the muscle. That functional answer — reversible versus fixed, and how much muscle is at risk — is what changes management, and it's the whole reason this study exists.